Inventories	6 Months Ended
Sep. 30, 2024
Inventories [Abstract]
INVENTORIES	Note 6 – INVENTORIES As of September 30, 2024 and March 31, 2024, inventory consisted of finished goods, which were medical devices such as cardioverter-defibrillators and anesthesia laryngoscope, valued at US$ 196,724 and US$ 191,201, respectively. The Company constantly monitors its potential obsolete products. Any loss on damaged items is immaterial and will be recognized immediately. As a result, no reserves were made for inventory as of September 30, 2024 and March 31, 2024, respectively.

The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 330
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/330/tableOfContent

Name:	us-gaap_InventoryDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration